Advertisement

A qualitative synthesis of the evidence behind elective lymph node irradiation in oesophageal cancer

Published:November 25, 2014DOI:https://doi.org/10.1016/j.radonc.2014.11.010

      Abstract

      Background and purpose: Oesophageal cancer is the sixth leading cause of cancer death worldwide and radiotherapy plays a prominent role in its treatment. The presence of lymph node (LN) metastasis has been demonstrated to be one of the most significant prognostic factors related to oesophageal cancer. The use of elective lymph node irradiation (ENI) is still a topic of persistent controversy. The conservative school is to irradiate positive lymph nodes only; the other school is to prophylactically irradiate the regional lymph node area according to different tumour sites. This review investigated the justification for including ENI in the treatment of patients with oesophageal cancer. Material and methods: We performed a systematic literature search to find surgical data about lymph node distribution depending on different tumour subgroups: early, cervical, thoracic and gastroesophageal junction cancer. Furthermore, we performed a qualitative assessment of recurrence patterns in patients treated with or without ENI to derive estimates of the potential area at risk for lymph node harvest. Results: We identified and reviewed 49 studies: 10 in early, 8 in cervical, 10 in thoracic and the remaining 21 in gastroesophageal junction cancer. In general, these studies were conclusive in incidence and location of pathologic lymph nodes for different subgroups. Data for lymph node recurrence patterns are scarce and contributed little to our review. Conclusions: This review resulted in five recommendations for radiation oncologists in daily practice. We used the available evidence about metastatic lymph node distribution to develop a careful reasonable radiation protocol for the corresponding tumour subgroups.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Radiotherapy and Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Daly J.M.
        • Fry W.A.
        • Little A.G.
        • et al.
        Esophageal cancer: results of an American college of surgeons patient care evaluation study.
        J Am Coll Surg. 2000; 190 ([discussion 72–3]): 562-572
        • Dresner S.M.
        • Lamb P.J.
        • Bennett M.K.
        • et al.
        The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction.
        Surgery. 2001; 129: 103-109
        • Griffith J.L.
        • Davis J.T.
        A twenty-year experience with surgical management of carcinoma of the esophagus and gastric cardia.
        J Thorac Cardiovasc Surg. 1980; 79: 447-452
        • Matthews H.R.
        • Steel A.
        Left-sided subtotal oesophagectomy for carcinoma.
        Br J Surg. 1987; 74: 1115-1117
        • Mueller J.D.
        • Stein H.J.
        • Oyang T.
        • et al.
        Frequency and clinical impact of lymph node micrometastasis and tumor cell microinvolvement in patients with adenocarcinoma of the esophagogastric junction.
        Cancer. 2000; 89: 1874-1882
        • Lerut T.
        • De Leyn P.
        • Coosemans W.
        • et al.
        Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy.
        Ann Surg. 1992; 216: 583-590
        • Mariette C.
        • Finzi L.
        • Piessen G.
        • et al.
        Esophageal carcinoma: prognostic differences between squamous cell carcinoma and adenocarcinoma.
        World J Surg. 2005; 29: 39-45
        • Fiorica F.
        • Di Bona D.
        • Schepis F.
        • et al.
        Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis.
        Gut. 2004; 53: 925-930
        • Holscher A.H.
        • Bollschweiler E.
        • Schneider P.M.
        • Siewert J.R.
        Prognosis of early esophageal cancer. Comparison between adeno- and squamous cell carcinoma.
        Cancer. 1995; 76: 178-186
        • Siewert J.R.
        • Stein H.J.
        • Feith M.
        • et al.
        Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1000 consecutive resections at a single center in the Western world.
        Ann Surg. 2001; 234 ([Discussion 8–9]): 360-367
        • van Hagen P.
        • Hulshof M.C.
        • van Lanschot J.J.
        • et al.
        Preoperative chemoradiotherapy for esophageal or junctional cancer.
        N Engl J Med. 2012; 366: 2074-2084
        • Klautke G.
        • Fietkau R.
        Significance of radiation therapy for adenocarcinomas of the esophagus, gastroesophageal junction and gastric cancer with special reference to the MAGIC trial.
        Strahlenther Onkol. 2007; 183: 163-169
        • Bollschweiler E.
        • Schroder W.
        • Holscher A.H.
        • Siewert J.R.
        Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus.
        Br J Surg. 2000; 87: 1106-1110
        • Prenzel K.L.
        • Bollschweiler E.
        • Schroder W.
        • et al.
        Prognostic relevance of skip metastases in esophageal cancer.
        Ann Thorac Surg. 2010; 90: 1662-1667
        • Tachibana M.
        • Dhar D.K.
        • Kinugasa S.
        • et al.
        Esophageal cancer with distant lymph node metastasis: prognostic significance of metastatic lymph node ratio.
        J Clin Gastroenterol. 2000; 31: 318-322
        • Stahl M.
        • Walz M.K.
        • Stuschke M.
        • et al.
        Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction.
        J Clin Oncol. 2009; 27: 851-856
        • Muijs C.
        • Smit J.
        • Karrenbeld A.
        • et al.
        Residual tumor after neoadjuvant chemoradiation outside the radiation therapy target volume: a new prognostic factor for survival in esophageal cancer.
        Int J Radiat Oncol Biol Phys. 2014; 88: 845-852
        • Rohatgi P.R.
        • Swisher S.G.
        • Correa A.M.
        • et al.
        Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy.
        Cancer. 2006; 106: 552-558
        • Fakhrian K.
        • Ordu A.D.
        • Lordick F.
        • et al.
        Long-term outcomes of trimodality treatment for squamous cell carcinoma of the esophagus with cisplatin and/or 5-FU: more than 20 years experience at a single institution.
        Strahlenther Onkol. 2014; ([Epub ahead of print])
        • Natsugoe S.
        • Yoshinaka H.
        • Shimada M.
        • et al.
        Number of lymph node metastases determined by presurgical ultrasound and endoscopic ultrasound is related to prognosis in patients with esophageal carcinoma.
        Ann Surg. 2001; 234: 613-618
        • Izbicki J.R.
        • Hosch S.B.
        • Pichlmeier U.
        • et al.
        Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer.
        N Engl J Med. 1997; 337: 1188-1194
        • Thompson S.K.
        • Ruszkiewicz A.R.
        • Jamieson G.G.
        • et al.
        Isolated tumor cells in esophageal cancer: implications for the surgeon and the pathologist.
        Ann Surg. 2010; 252: 299-306
        • Wang D.
        • Smit J.K.
        • Zwaan E.
        • et al.
        Neoadjuvant therapy reduces the incidence of nodal micrometastases in esophageal adenocarcinoma.
        Am J Surg. 2013; 206: 732-738
        • Matsumoto M.
        • Natsugoe S.
        • Nakashima S.
        • et al.
        Clinical significance of lymph node micrometastasis of pN0 esophageal squamous cell carcinoma.
        Cancer Lett. 2000; 153: 189-197
        • Prenzel K.L.
        • Konig A.
        • Schneider P.M.
        • et al.
        Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancer.
        Ann Surg Oncol. 2007; 14: 954-959
        • Bonavina L.
        • Ferrero S.
        • Midolo V.
        • et al.
        Lymph node micrometastases in patients with adenocarcinoma of the esophagogastric junction.
        J Gastrointest Surg. 1999; 3: 468-476
        • Rades D.
        • Schulte R.
        • Yekebas E.F.
        • et al.
        Radio(chemo)therapy plus resection versus radio(chemo)therapy alone for the treatment of stage III esophageal cancer.
        Strahlenther Onkol. 2007; 183: 10-16
        • Toita T.
        • Ogawa K.
        • Adachi G.
        • et al.
        Concurrent chemoradiotherapy for squamous cell carcinoma of thoracic esophagus: feasibility and outcome of large regional field and high-dose external beam boost irradiation.
        Jpn J Clin Oncol. 2001; 31: 375-381
        • Lee J.L.
        • Park S.I.
        • Kim S.B.
        • et al.
        A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma.
        Ann Oncol. 2004; 15: 947-954
        • Vallbohmer D.
        • Holscher A.H.
        • DeMeester S.
        • et al.
        A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer.
        Ann Surg. 2010; 252: 744-749
        • Leibl B.J.
        • Vitz S.
        • Schafer W.
        • et al.
        Adenocarcinoma of the esophagogastric junction: neoadjuvant radiochemotherapy and radical surgery: early results and toxicity.
        Strahlenther Onkol. 2011; 187: 231-237
        • Juloori A.
        • Tucker S.L.
        • Komaki R.
        • et al.
        Influence of preoperative radiation field on postoperative leak rates in esophageal cancer patients after trimodality therapy.
        J Thorac Oncol. 2014; 9: 534-540
        • Vande Walle C.
        • Ceelen W.P.
        • Boterberg T.
        • Vande Putte D.
        • Van Nieuwenhove Y.
        • Varin O.
        • Pattyn P.
        Anastomotic complications after Ivor Lewis esophagectomy in patients treated with neoadjuvant chemoradiation are related to radiation dose to the gastric fundus.
        Int J Radiat Oncol Biol Phys. 2012; 82: e513-e519
        • Ji K.
        • Zhao L.
        • Yang C.
        • et al.
        Three-dimensional conformal radiation for esophageal squamous cell carcinoma with involved-field irradiation may deliver considerable doses of incidental nodal irradiation.
        Radiat Oncol. 2012; 7: 200
        • Alper F.
        • Turkyilmaz A.
        • Kurtcan S.
        • et al.
        Effectiveness of the STIR turbo spin-echo sequence MR imaging in evaluation of lymphadenopathy in esophageal cancer.
        Eur J Radiol. 2011; 80: 625-628
        • Schroder W.
        • Baldus S.E.
        • Monig S.P.
        • et al.
        Lymph node staging of esophageal squamous cell carcinoma in patients with and without neoadjuvant radiochemotherapy: histomorphologic analysis.
        World J Surg. 2002; 26: 584-587
        • Blom R.L.
        • Steenbakkers I.R.
        • Lammering G.
        • et al.
        PET/CT-based metabolic tumour volume for response prediction of neoadjuvant chemoradiotherapy in oesophageal carcinoma.
        Eur J Nucl Med Mol Imaging. 2013; 40: 1500-1506
        • Korst R.J.
        • Rusch V.W.
        • Venkatraman E.
        • et al.
        Proposed revision of the staging classification for esophageal cancer.
        J Thorac Cardiovasc Surg. 1998; 115 ([Discussion 9–70]): 660-669
        • Akiyama H.
        Surgery for carcinoma of the esophagus.
        Curr Probl Surg. 1980; 17: 53-120
        • Tajima Y.
        • Nakanishi Y.
        • Ochiai A.
        • et al.
        Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors.
        Cancer. 2000; 88: 285-293
        • Ancona E.
        • Rampado S.
        • Cassaro M.
        • Battaglia G.
        • Ruol A.
        • Castoro C.
        • Portale G.
        • Cavallin F.
        • Rugge M.
        Prediction of lymph node status in superficial esophageal carcinoma.
        Ann Surg Oncol. 2008; 15: 3278-3288
        • Barbour A.P.
        • Jones M.
        • Brown I.
        • et al.
        Risk stratification for early esophageal adenocarcinoma: analysis of lymphatic spread and prognostic factors.
        Ann Surg Oncol. 2010; 17: 2494-2502
        • Bollschweiler E.
        • Baldus S.E.
        • Schroder W.
        • et al.
        High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas.
        Endoscopy. 2006; 38: 149-156
        • Buskens C.J.
        • Westerterp M.
        • Lagarde S.M.
        • et al.
        Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features.
        Gastrointest Endosc. 2004; 60: 703-710
        • Endo M.
        • Yoshino K.
        • Kawano T.
        • Nagai K.
        • Inoue H.
        Clinicopathologic analysis of lymph node metastasis in surgically resected superficial cancer of the thoracic esophagus.
        Dis Esophagus. 2000; 13: 125-129
        • Leers J.M.
        • DeMeester S.R.
        • Oezcelik A.
        • Klipfel N.
        • Ayazi S.
        • Abate E.
        • Zehetner J.
        • Lipham J.C.
        • et al.
        The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens.
        Ann Surg. 2011; 253: 271-278
        • Li B.
        • Chen H.
        • Xiang J.
        • Zhang Y.
        • Kong Y.
        • Garfield D.H.
        • et al.
        Prevalence of lymph node metastases in superficial esophageal squamous cell carcinoma.
        J Thorac Cardiovasc Surg. 2013; 146: 1198-1203
        • Sepesi B.
        • Watson T.J.
        • Zhou D.
        • Polomsky M.
        • Litle V.R.
        • Jones C.E.
        • Raymond D.P.
        • Hu R.
        • Qiu X.
        Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens.
        J Am Coll Surg. 2010; 210: 418-427
        • Shimada H.
        • Nabeya Y.
        • Matsubara H.
        • et al.
        Prediction of lymph node status in patients with superficial esophageal carcinoma: analysis of 160 surgically resected cancers.
        Am J Surg. 2006; 191: 250-254
        • Westerterp M.
        • Koppert L.B.
        • Buskens C.J.
        • Tilanus H.W.
        • ten Kate F.J.
        • Bergman J.J.
        • Siersema P.D.
        • van Dekken H.
        • van Lanschot J.J.
        Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction.
        Virchows Arch. 2005; 446: 497-504
        • Nemoto K.
        • Yamada S.
        • Nishio M.
        • et al.
        Results of radiation therapy for superficial esophageal cancer using the standard radiotherapy method recommended by the Japanese Society of Therapeutic Radiology and Oncology (JASTRO) study group.
        Anticancer Res. 2006; 26: 1507-1512
        • Kato H.
        • Igaki H.
        • Tachimori Y.
        • et al.
        Assessment of cervical lymph node metastasis in the staging of thoracic esophageal carcinoma.
        J Surg Oncol. 2000; 74: 282-285
        • Okawa T.
        • Tanaka M.
        • Kita-Okawa M.
        • et al.
        Superficial esophageal cancer: multicenter analysis of results of definitive radiation therapy in Japan.
        Radiology. 1995; 196: 271-274
        • Stein H.J.
        • Feith M.
        • Bruecher B.L.
        • et al.
        Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection.
        Ann Surg. 2005; 242 ([Discussion 73–5]): 566-573
        • Ishikawa H.
        • Sakurai H.
        • Tamaki Y.
        • et al.
        Radiation therapy alone for stage I (UICC T1N0M0) squamous cell carcinoma of the esophagus: indications for surgery or combined chemoradiotherapy.
        J Gastroenterol Hepatol. 2006; 21: 1290-1296
        • Sasaki T.
        • Nakamura K.
        • Shioyama Y.
        • et al.
        Treatment outcomes of radiotherapy for patients with stage I esophageal cancer: a single institute experience.
        Am J Clin Oncol. 2007; 30: 514-519
        • Motoori M.
        • Yano M.
        • Ishihara R.
        • et al.
        Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer.
        Ann Surg Oncol. 2012; 19: 2135-2141
        • Cao C.N.
        • Liu S.Y.
        • Luo J.W.
        • et al.
        Pattern of failure in surgically treated patients with cervical esophageal squamous cell carcinoma.
        Otolaryngol Head Neck Surg. 2014; 151: 260-264
        • Tong D.K.
        • Law S.
        • Kwong D.L.
        • et al.
        Current management of cervical esophageal cancer.
        World J Surg. 2011; 35: 600-607
        • Hirano S.
        • Nagahara K.
        • Moritani S.
        • et al.
        Upper mediastinal node dissection for hypopharyngeal and cervical esophageal carcinomas.
        Ann Otol Rhinol Laryngol. 2007; 116: 290-296
        • Martins A.S.
        Neck and mediastinal node dissection in pharyngolaryngoesophageal tumors.
        Head Neck. 2001; 23: 772-779
        • Timon C.V.
        • Toner M.
        • Conlon B.J.
        Paratracheal lymph node involvement in advanced cancer of the larynx, hypopharynx, and cervical esophagus.
        Laryngoscope. 2003; 113: 1595-1599
        • Weber R.S.
        • Marvel J.
        • Smith P.
        • et al.
        Paratracheal lymph node dissection for carcinoma of the larynx, hypopharynx, and cervical esophagus.
        Otolaryngol Head Neck Surg. 1993; 108: 11-17
        • Lerut T.
        • Nafteux P.
        • Moons J.
        • et al.
        Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma.
        Ann Surg. 2004; 240 ([Discussion 72–4]): 962-972
        • Burmeister B.H.
        • Smithers B.M.
        • Gebski V.
        • et al.
        Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.
        Lancet Oncol. 2005; 6: 659-668
        • Gkika E.
        • Gauler T.
        • Eberhardt W.
        • et al.
        Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus.
        Dis Esophagus. 2013; 27: 678-684
        • Yamada K.
        • Murakami M.
        • Okamoto Y.
        • et al.
        Treatment results of radiotherapy for carcinoma of the cervical esophagus.
        Acta Oncol. 2006; 45: 1120-1125
        • Ding X.
        • Zhang J.
        • Li B.
        • et al.
        A meta-analysis of lymph node metastasis rate for patients with thoracic oesophageal cancer and its implication in delineation of clinical target volume for radiation therapy.
        Br J Radiol. 2012; 85: e1110-9
        • Lu J.C.
        • Tao H.
        • Zhang Y.Q.
        • et al.
        Extent of prophylactic postoperative radiotherapy after radical surgery of thoracic esophageal squamous cell carcinoma.
        Dis Esophagus. 2008; 21: 502-507
        • Murakami M.
        • Kuroda Y.
        • Nakajima T.
        • et al.
        Intraoperative radiotherapy for the abdominal lymphatic system in patients with esophageal carcinoma.
        Dis Esophagus. 1999; 12: 270-275
        • Denham J.W.
        • Steigler A.
        • Kilmurray J.
        • et al.
        Relapse patterns after chemo-radiation for carcinoma of the oesophagus.
        Clin Oncol (R Coll Radiol). 2003; 15: 98-108
        • Hsu F.M.
        • Lee J.M.
        • Huang P.M.
        • et al.
        Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma.
        Int J Radiat Oncol Biol Phys. 2011; 81: e593-9
        • Siewert J.R.
        • Stein H.J.
        Classification of adenocarcinoma of the oesophagogastric junction.
        Br J Surg. 1998; 85: 1457-1459
        • Matzinger O.
        • Gerber E.
        • Bernstein Z.
        • et al.
        EORTC-ROG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach.
        Radiother Oncol. 2009; 92: 164-175
        • Goto H.
        • Tokunaga M.
        • Miki Y.
        • et al.
        The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type II and Siewert type III patients.
        Gastric Cancer. 2014; ([Epub ahead of print])
        • Yamashita H.
        • Katai H.
        • Morita S.
        • et al.
        Optimal extent of lymph node dissection for Siewert type II esophagogastric junction carcinoma.
        Ann Surg. 2011; 254: 274-280
        • Rino Y.
        • Yukawa N.
        • Sato T.
        • et al.
        Visualization of blood supply route to the reconstructed stomach by indocyanine green fluorescence imaging during esophagectomy.
        BMC Med Imaging. 2014; 14: 18
        • Tachimori Y.
        • Kato H.
        • Watanabe H.
        • et al.
        Difference between carcinoma of the lower esophagus and the cardia.
        World J Surg. 1996; 20 ([Discussion 11]): 507-510
        • van de Ven C.
        • De Leyn P.
        • Coosemans W.
        • et al.
        Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction.
        Eur J Cardiothorac Surg. 1999; 15: 769-773
        • Oppedijk V.
        • van der Gaast A.
        • van Lanschot J.J.
        • et al.
        Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials.
        J Clin Oncol. 2014; 32: 385-391
        • Koshy M.
        • Greenwald B.D.
        • Hausner P.
        • Krasna M.J.
        • Horiba N.
        • Battafarano R.J.
        • Burrows W.
        • Suntharalingam M.
        Outcomes after trimodality therapy for esophageal cancer: the impact of histology on failure patterns.
        Am J Clin Oncol. 2011; 34: 259-264
        • Meguid R.A.
        • Hooker C.M.
        • Taylor J.T.
        • et al.
        Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: does the pattern of recurrence differ for patients with complete response and those with partial or no response?.
        J Thorac Cardiovasc Surg. 2009; 138: 1309-1317
        • Sudo K.
        • Taketa T.
        • Correa A.M.
        • et al.
        Locoregional failure rate after preoperative chemoradiation of esophageal adenocarcinoma and the outcomes of salvage strategies.
        J Clin Oncol. 2013; 31: 4306-4310
        • Smit J.K.
        • Guler S.
        • Beukema J.C.
        • et al.
        Different recurrence pattern after neoadjuvant chemoradiotherapy compared to surgery alone in esophageal cancer patients.
        Ann Surg Oncol. 2013; 20: 4008-4015
        • Comen E.
        • Norton L.
        Self-seeding in cancer.
        Recent Results Cancer Res. 2012; 195: 13-23
        • Adenis A.
        • Tresch E.
        • Dewas S.
        • et al.
        Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcome.
        BMC Cancer. 2013; 13: 413
        • Bedenne L.
        • Michel P.
        • Bouche O.
        • et al.
        Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.
        J Clin Oncol. 2007; 25: 1160-1168
        • Reid T.D.
        • Davies I.L.
        • Mason J.
        • et al.
        Stage for stage comparison of recurrence patterns after definitive chemoradiotherapy or surgery for oesophageal carcinoma.
        Clin Oncol (R Coll Radiol). 2012; 24: 617-624
        • Onozawa M.
        • Nihei K.
        • Ishikura S.
        • et al.
        Elective nodal irradiation (ENI) in definitive chemoradiotherapy (CRT) for squamous cell carcinoma of the thoracic esophagus.
        Radiother Oncol. 2009; 92: 266-269
        • Yamashita H.
        • Okuma K.
        • Wakui R.
        • et al.
        Details of recurrence sites after elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) combined with chemotherapy for thoracic esophageal squamous cell carcinoma – A retrospective analysis.
        Radiother Oncol. 2011; 98: 255-260
        • Zhao K.L.
        • Ma J.B.
        • Liu G.
        • et al.
        Three-dimensional conformal radiation therapy for esophageal squamous cell carcinoma: is elective nodal irradiation necessary?.
        Int J Radiat Oncol Biol Phys. 2010; 76: 446-451
        • Morota M.
        • Gomi K.
        • Kozuka T.
        • et al.
        Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma.
        Int J Radiat Oncol Biol Phys. 2009; 75: 122-128
        • Zhang X.
        • Li M.
        • Meng X.
        • et al.
        Involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
        Radiat Oncol. 2014; 9: 64
        • Cooper J.S.
        • Guo M.D.
        • Herskovic A.
        • et al.
        Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85–01).
        Radiation Therapy Oncology Group. JAMA. 1999; 281: 1623-1627
        • Minsky B.D.
        • Pajak T.F.
        • Ginsberg R.J.
        • et al.
        INT 0123 (Radiation Therapy Oncology Group 94–05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy.
        J Clin Oncol. 2002; 20: 1167-1174
        • Amini A.
        • Xiao L.
        • Allen P.K.
        • et al.
        Celiac node failure patterns after definitive chemoradiation for esophageal cancer in the modern era.
        Int J Radiat Oncol Biol Phys. 2012; 83: e231-9
        • Meier I.
        • Merkel S.
        • Papadopoulos T.
        • Sauer R.
        • Hohenberger W.
        • Brunner T.B.
        Adenocarcinoma of the esophagogastric junction: the pattern of metastatic lymph node dissemination as a rationale for elective lymphatic target volume definition.
        Int J Radiat Oncol Biol Phys. 2008; 70: 1408-1417
        • Meldolesi E.
        • van Soest J.
        • Dinapoli N.
        • et al.
        An umbrella protocol for standardized data collection (SDC) in rectal cancer: A prospective uniform naming and procedure convention to support personalized medicine.
        Radiother Oncol. 2014; 112: 59-62
        • Roelofs E.
        • Persoon L.
        • Nijsten S.
        • et al.
        Benefits of a clinical data warehouse with data mining tools to collect data for a radiotherapy trial.
        Radiother Oncol. 2013; 108: 174-179
        • Gu Y.
        • Swisher S.G.
        • Ajani J.A.
        • et al.
        The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation.
        Cancer. 2006; 106: 1017-1025
        • Hasegawa S.
        • Yoshikawa T.
        • Rino Y.
        • et al.
        Priority of lymph node dissection for Siewert type II/III adenocarcinoma of the esophagogastric junction.
        Ann Surg Oncol. 2013; 20: 4252-4259
        • Mine S.
        • Sano T.
        • Hiki N.
        • et al.
        Lymphadenectomy around the left renal vein in Siewert type II adenocarcinoma of the oesophagogastric junction.
        Br J Surg. 2013; 100: 261-266
        • Igaki H.
        • Kato H.
        • Tachimori Y.
        • Nakanishi Y.
        Cervical lymph node metastasis in patients with submucosal carcinoma of the thoracic esophagus.
        J Surg Oncol. 2000; 75: 37-41
        • Tachimori Y.
        • Nagai Y.
        • Kanamori N.
        • et al.
        Pattern of lymph node metastases of esophageal squamous cell carcinoma based on the anatomical lymphatic drainage system.
        Dis Esophagus. 2011; 24: 33-38
        • Kosugi S.
        • Kawaguchi Y.
        • Kanda T.
        • Ishikawa T.
        • Sakamoto K.
        • Akaike H.
        • Fujii H.
        • et al.
        Cervical lymph node dissection for clinically submucosal carcinoma of the thoracic esophagus.
        Ann Surg Oncol. 2013; 20: 4016-4021
        • Gertler R.
        • Stein H.J.
        • Schuster T.
        • et al.
        Prevalence and topography of lymph node metastases in early esophageal and gastric cancer.
        Ann Surg. 2014; 259: 96-101
        • Akiyama H.
        • Tsurumaru M.
        • Udagawa H.
        • Kajiyama Y.
        Radical lymph node dissection for cancer of the thoracic esophagus.
        Ann Surg. 1994; 220 ([Discussion 72–3]): 364-372
        • Tsurumaru M.
        • Kajiyama Y.
        • Udagawa H.
        • Akiyama H.
        Outcomes of extended lymph node dissection for squamous cell carcinoma of the thoracic esophagus.
        Ann Thorac Cardiovasc Surg. 2001; 7: 325-329
        • Cai W.J.
        • Xin P.L.
        Pattern of relapse in surgical treated patients with thoracic esophageal squamous cell carcinoma and its possible impact on target delineation for postoperative radiotherapy.
        Radiother Oncol. 2010; 96: 104-107
        • Li B.
        • Chen H.
        • Xiang J.
        • Zhang Y.
        • Li C.
        • Hu H.
        Pattern of lymphatic spread in thoracic esophageal squamous cell carcinoma: A single-institution experience.
        J Thorac Cardiovasc Surg. 2012; 144 ([Discussion 785–6]): 778-785
        • Hsu P.K.
        • Huang C.S.
        • Hsieh C.C.
        • et al.
        Role of right upper mediastinal lymph node metastasis in patients with esophageal squamous cell carcinoma after tri-incisional esophagectomies.
        Surgery. 2014; ([Epub ahead of print])
        • Nigro J.J.
        • Hagen J.A.
        • DeMeester T.R.
        • et al.
        Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy.
        J Thorac Cardiovasc Surg. 1999; 117 ([Discussion 5]): 16-23
        • Feith M.
        • Stein H.J.
        • Siewert J.R.
        Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients.
        Surg Oncol Clin N Am. 2006; 15: 751-764
        • Pedrazzani C.
        • de Manzoni G.
        • Marrelli D.
        • et al.
        Lymph node involvement in advanced gastroesophageal junction adenocarcinoma.
        J Thorac Cardiovasc Surg. 2007; 134: 378-385
        • Wang L.S.
        • Wu C.W.
        • Hsieh M.J.
        • et al.
        Lymph node metastasis in patients with adenocarcinoma of gastric cardia.
        Cancer. 1993; 71: 1948-1953
        • Rudiger Siewert J.
        • Feith M.
        • Werner M.
        • Stein H.J.
        Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1002 consecutive patients.
        Ann Surg. 2000; 232: 353-361
        • Schroder W.
        • Monig S.P.
        • Baldus S.E.
        • et al.
        Frequency of nodal metastases to the upper mediastinum in Barrett’s cancer.
        Ann Surg Oncol. 2002; 9: 807-811
        • Hulscher J.B.
        • Van Sandick J.W.
        • Offerhaus G.J.
        • et al.
        Prospective analysis of the diagnostic yield of extended en bloc resection for adenocarcinoma of the oesophagus or gastric cardia.
        Br J Surg. 2001; 88: 715-719
        • Lagarde S.M.
        • Cense H.A.
        • Hulscher J.B.
        • et al.
        Prospective analysis of patients with adenocarcinoma of the gastric cardia and lymph node metastasis in the proximal field of the chest.
        Br J Surg. 2005; 92: 1404-1408
        • Ielpo B.
        • Pernaute A.S.
        • Elia S.
        • et al.
        Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction.
        Interact Cardiovasc Thorac Surg. 2010; 10: 704-708
        • Kakeji Y.
        • Yamamoto M.
        • Ito S.
        • et al.
        Lymph node metastasis from cancer of the esophagogastric junction, and determination of the appropriate nodal dissection.
        Surg Today. 2012; 42: 351-358